Institut National d'Etude et d'Action pour le Developpement de l'Education, Senegal Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2011
NCT01454752
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (3)

amodiaquine (camoquin) (1 trial)

pyrimethamine (daraprim) (1 trial)

sulfadoxine (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 3